NCMHCE - National Clinical Mental Health Counseling Examination National Clinical Mental Health Counseling Examination Psychopharmacology and Co-occurring Disorders 1

Question 1

A client with co-occurring major depressive disorder and opioid use disorder is stabilized on buprenorphine/naloxone (Suboxone) and asks whether they should also be taking an antidepressant. What is the MOST appropriate counselor response?

Accepted Answer

Encourage the client to discuss this with their prescribing physician, as integrated pharmacological treatment may benefit both conditions

Answer

The counselor's role is to support integrated care while respecting scope of practice. Referring the client to their prescriber for medication decisions is appropriate, as evidence supports treating co-occurring depression and opioid use disorder simultaneously within a coordinated care model.

Question 2

A counselor observes that a client taking a second-generation (atypical) antipsychotic has gained 25 pounds over three months and now reports increased thirst and frequent urination. What is the MOST appropriate counselor action?

Accepted Answer

Refer the client to their prescribing physician to evaluate for metabolic syndrome

Answer

Second-generation antipsychotics carry a well-documented risk for metabolic syndrome, including weight gain, hyperglycemia, and dyslipidemia. Increased thirst and urination may indicate new-onset diabetes. The counselor should promptly refer to the prescriber for medical evaluation rather than minimizing or independently managing these symptoms.

Question 3

A client with co-occurring generalized anxiety disorder and alcohol use disorder has been abstinent for 30 days. Their psychiatrist recommends buspirone for anxiety management. Why is buspirone PARTICULARLY well-suited for this client compared to benzodiazepines?

Accepted Answer

Buspirone is non-habit-forming and has no cross-tolerance with alcohol

Answer

Buspirone is an azapirone anxiolytic that carries no dependence risk and has no cross-tolerance with alcohol or benzodiazepines, making it significantly safer for clients with alcohol use disorder. Unlike benzodiazepines, it does not potentiate alcohol's CNS depressant effects and takes several weeks to reach full efficacy.

Question 4

A client diagnosed with schizophrenia and cannabis use disorder insists that smoking cannabis helps control their psychotic symptoms better than their prescribed antipsychotic. How should the counselor BEST respond?

Accepted Answer

Acknowledge the client's perception while providing psychoeducation that THC can exacerbate psychotic symptoms and reduce antipsychotic effectiveness

Answer

Research consistently shows that THC in cannabis can worsen psychotic symptoms, increase relapse risk, and reduce antipsychotic efficacy in clients with schizophrenia spectrum disorders. The counselor should validate the client's experience empathically while delivering accurate psychoeducation to support informed treatment decisions.

Question 5

A client with co-occurring ADHD and stimulant use disorder asks about medication options for managing their ADHD symptoms. Which statement BEST reflects current clinical guidance for this population?

Accepted Answer

Non-stimulant options such as atomoxetine may be preferred, and if stimulants are used, long-acting formulations with careful monitoring are recommended

Answer

Clients with co-occurring ADHD and stimulant use disorder can receive ADHD treatment, but clinicians often prefer non-stimulant medications like atomoxetine or bupropion to reduce misuse risk. If stimulants are prescribed, extended-release formulations are favored due to lower abuse potential and diversion risk, combined with close monitoring.

NCMHCE - National Clinical Mental Health Counseling Examination Practice Test

NCMHCE - National Clinical Mental Health Counseling Examination Practice Test

NCMHCE - National Clinical Mental Health Counseling Examination National Clinical Mental Health Counseling Examination Psychopharmacology and Co-occurring Disorders 1